Brief: Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling
20/11/2025 13:53
Aeon Biopharma Inc AEON.A: AEON BIOPHARMA ANNOUNCES FIRST CLOSING OF PIPE INVESTMENT AND PROVIDES UPDATE ON FDA TYPE 2A MEETING SCHEDULING AEON BIOPHARMA INC: FDA BPD TYPE 2A MEETING NOW SCHEDULED FOR JANUARY 21, 2026 AEON BIOPHARMA INC - FIRST CLOSING OF PIPE RESULTS IN $1.79 MILLION PROCEEDS Source text: ID:nGNX8LCqSW Further company coverage: AEON.A
Recent news on Aeon Biopharma
See all newsBrief: Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions
Brief: Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong
Brief: Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling
Brief: Aeon Biopharma Announces FDA bpd Type 2A Meeting For Abp-450 On November 19
Brief: Aeon Biopharma Announces CEO Transition